Search research articles
Contact Us
Filters
Showing results (71-80 of 292) with videos related to
Page
of 30
Sort By:
Biochemical Society Transactions
|
December 1, 1990
Pepsin 5 (gastricsin): atypical pH profile of mucolytic activity
J P Pearson, A Blackburn, A Allen, et al.
Mediators of Inflammation
|
June 19, 2004
The immunoregulatory and allergy-associated cytokines in the aetiology of the otitis media with effusion
Marina G Smirnova, John P Birchall, Jeffrey P Pearson
Acta Oto-Laryngologica
|
April 9, 2002
In vitro study of IL-8 and goblet cells: possible role of IL-8 in the aetiology of otitis media with effusion
Marina G Smirnova, John P Birchall, Jeffrey P Pearson
Lancet (London, England)
|
June 11, 1983
Carrier detection in Duchenne muscular dystrophy by use of cloned DNA sequences
P Wieacker, K Davies, P Pearson, et al.
The American Journal of Surgical Pathology
|
June 1, 1996
Cutaneous malignant melanotic neurocristic tumors arising in neurocristic hamartomas. A melanocytic tumor morphologically and biologically distinct from common melanoma
J P Pearson, S W Weiss, J T Headington
Biochimica Et Biophysica Acta
|
September 7, 1982
The composition and polymeric structure of mucus glycoprotein from human gallbladder bile
J P Pearson, R Kaura, W Taylor, et al.
Journal of Medical Genetics
|
April 16, 2002
A school based study of children with learning disability indicates poor levels of genetic investigation
D R FitzPatrick, P Pearson, S Halpin, et al.
Advanced Drug Delivery Reviews
|
December 17, 2017
Efficacy and safety concerns over the use of mucus modulating agents for drug delivery using nanoscale systems
Peter I Chater, Matthew D Wilcox, Jeffrey P Pearson
Neuropharmacology
|
December 9, 2014
Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy
Farinaz Nasirinezhad, Stanislava Jergova, James P Pearson, et al.
Therapeutic Delivery
|
March 25, 2016
The properties of the mucus barrier, a unique gel--how can nanoparticles cross it?
Jeffrey P Pearson, Peter I Chater, Matthew D Wilcox
Page
of 30
Search research articles
Search
Showing results (71-80 of 292) with videos related to
Sort By:
Page
of 30
Biochemical Society Transactions
|
December 1, 1990
Pepsin 5 (gastricsin): atypical pH profile of mucolytic activity
J P Pearson, A Blackburn, A Allen, et al.
Mediators of Inflammation
|
June 19, 2004
The immunoregulatory and allergy-associated cytokines in the aetiology of the otitis media with effusion
Marina G Smirnova, John P Birchall, Jeffrey P Pearson
Acta Oto-Laryngologica
|
April 9, 2002
In vitro study of IL-8 and goblet cells: possible role of IL-8 in the aetiology of otitis media with effusion
Marina G Smirnova, John P Birchall, Jeffrey P Pearson
Lancet (London, England)
|
June 11, 1983
Carrier detection in Duchenne muscular dystrophy by use of cloned DNA sequences
P Wieacker, K Davies, P Pearson, et al.
The American Journal of Surgical Pathology
|
June 1, 1996
Cutaneous malignant melanotic neurocristic tumors arising in neurocristic hamartomas. A melanocytic tumor morphologically and biologically distinct from common melanoma
J P Pearson, S W Weiss, J T Headington
Biochimica Et Biophysica Acta
|
September 7, 1982
The composition and polymeric structure of mucus glycoprotein from human gallbladder bile
J P Pearson, R Kaura, W Taylor, et al.
Journal of Medical Genetics
|
April 16, 2002
A school based study of children with learning disability indicates poor levels of genetic investigation
D R FitzPatrick, P Pearson, S Halpin, et al.
Advanced Drug Delivery Reviews
|
December 17, 2017
Efficacy and safety concerns over the use of mucus modulating agents for drug delivery using nanoscale systems
Peter I Chater, Matthew D Wilcox, Jeffrey P Pearson
Neuropharmacology
|
December 9, 2014
Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy
Farinaz Nasirinezhad, Stanislava Jergova, James P Pearson, et al.
Therapeutic Delivery
|
March 25, 2016
The properties of the mucus barrier, a unique gel--how can nanoparticles cross it?
Jeffrey P Pearson, Peter I Chater, Matthew D Wilcox
Page
of 30